Article Details

Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor ...

Retrieved on: 2024-05-13 19:23:34

Tags for this article:

Click the tags to see associated articles and topics

Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor .... View article details on hiswai:

Excerpt

PHILADELPHIA, May 13, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing .

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up